Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women
Author(s) -
Aarthi Arasu,
Peggy M. Cawthon,
LiYung Lui,
Thy P.,
Puneet Arora,
Jane A. Cauley,
Kristine E. Ensrud,
Steven R. Cummings
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-3419
Subject(s) - sclerostin , medicine , quartile , hip fracture , confidence interval , cohort , bone mineral , body mass index , prospective cohort study , hazard ratio , cohort study , proportional hazards model , endocrinology , osteoporosis , biology , biochemistry , wnt signaling pathway , gene
Sclerostin, a protein secreted by osteocytes, inhibits bone formation. Individuals with genetic mutations that decrease the availability of sclerostin have very high bone mass.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom